MYCO.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 21, 2025

Report Source: 2025 1st Quarter Report

Analyst's Ratings for Mydecine Innovations Group Inc (MYCO.CN)

Based on 7 analysts giving stock ratings to Mydecine Innovations Group Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
57
Hold
14
Sell
0
Strong Sell
0
Mydecine Innovations Group Inc

Mydecine Innovations Group Inc. Stock Analysis MYCO.CN

Canada Health Care Nano Cap Report:
Mydecine Innovations Group Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-08-18. Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The firm is engaged in developing the next generation of medications and therapies to address mental health disorders, such as nicotine addiction and post traumatic stress disorder (PTSD). The firm conducts research and development on novel second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The firm has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The firm is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). The company uses advanced artificial intelligence (AI) and machine learning to design and screen drugs of interest. Its subsidiaries include Mydecine Group (1220611 BC Ltd) and NeuroPharm Inc.
Read More

Mydecine Innovations Group Inc (MYCO.CN) Chart

Key Statistics of Mydecine Innovations Group Inc (MYCO.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.42CAD0.42

Today's Open

CAD0.42

Volume

3725.00

P/E Ratio (TTM)

-

52 Week Range

CAD0.12CAD0.50

Market Cap

407.57K

Avg. Volume

22.93K

Dividend Yield

-

Financial Metrics & Statements of Mydecine Innovations Group Inc (MYCO.CN)

FAQ's for Mydecine Innovations Group Inc (MYCO.CN)

  • According to Musaffa’s Shariah screening methodology, Mydecine Innovations Group Inc (MYCO.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.